These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31325476)

  • 1. Phytic acid attenuates upregulation of GSK-3β and disturbance of synaptic vesicle recycling in MPTP-induced Parkinson's disease models.
    Wang L; Zhang Z; Hou L; Wang Y; Zuo J; Xue M; Li X; Liu Y; Song J; Pan F; Pu T
    Neurochem Int; 2019 Oct; 129():104507. PubMed ID: 31325476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 Inhibits MPP
    Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity.
    Bucher ML; Dunn AR; Bradner JM; Egerton KS; Burkett JP; Johnson MA; Miller GW
    Eur J Neurosci; 2024 May; 59(10):2483-2501. PubMed ID: 38532289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.
    Lohr KM; Chen M; Hoffman CA; McDaniel MJ; Stout KA; Dunn AR; Wang M; Bernstein AI; Miller GW
    Toxicol Sci; 2016 Sep; 153(1):79-88. PubMed ID: 27287315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
    Pifl C; Rajput A; Reither H; Blesa J; Cavada C; Obeso JA; Rajput AH; Hornykiewicz O
    J Neurosci; 2014 Jun; 34(24):8210-8. PubMed ID: 24920625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP
    Rani L; Ghosh B; Ahmad MH; Mondal AC
    Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.
    Luo L; Chen J; Su D; Chen M; Luo B; Pi R; Wang L; Shen W; Wang R
    Neurochem Res; 2017 Feb; 42(2):615-624. PubMed ID: 28078613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.
    Wang W; Yang Y; Ying C; Li W; Ruan H; Zhu X; You Y; Han Y; Chen R; Wang Y; Li M
    Neuropharmacology; 2007 Jun; 52(8):1678-84. PubMed ID: 17517424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
    Bao XQ; Kong XC; Qian C; Zhang D
    Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Deleidi M; Serapide MF; Pluchino S; Marchetti B
    J Neurosci; 2012 Feb; 32(6):2062-85. PubMed ID: 22323720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
    Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
    Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor.
    Sun X; Xiong Z; Zhang Y; Meng Y; Xu G; Xia Z; Li J; Zhang R; Ke Z; Xia Z; Hu Y
    J Neurochem; 2012 Mar; 120(6):1072-83. PubMed ID: 22192054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice.
    Litim N; Morissette M; Caruso D; Melcangi RC; Di Paolo T
    J Steroid Biochem Mol Biol; 2017 Nov; 174():242-256. PubMed ID: 28982631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity.
    Fang W; Gao G; Zhao H; Xia Y; Guo X; Li N; Li Y; Yang Y; Chen L; Wang Q; Li L
    Brain Res; 2015 Mar; 1602():9-19. PubMed ID: 25150591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of progesterone administered after MPTP on dopaminergic neurons of male mice.
    Litim N; Morissette M; Di Paolo T
    Neuropharmacology; 2017 May; 117():209-218. PubMed ID: 28192111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.